| Product Code: ETC312748 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
It was reported that antibiotics constituted around 13.1% of all medication sales within Indonesia pharmaceuticals sector ? amounting to approximately US$714 million in total revenue. Over the next few years however there has been an increase in global awareness about antibiotic resistance leading many governments including Indonesia?s government taking measures against excessive usage. As a result it?s predicted that by 2025 this figure will have decreased by 4% compared with its 2018 level; meaning overall revenue generated by antibiotics within Indonesia could decrease down to $686 million by 2025.
The antibiotic market in Indonesia is influenced by the country`s healthcare needs and prescription patterns. Factors such as population growth, urbanization, and increased access to healthcare services contribute to the demand for antibiotics. The prevalence of infectious diseases and the need to combat bacterial infections are key drivers for the antibiotic market. Additionally, government initiatives aimed at improving healthcare infrastructure and addressing healthcare-associated infections also play a role in shaping the market outlook.
The Indonesian antibiotic market plays a vital role in healthcare, yet the misuse and overuse of antibiotics raise concerns about antimicrobial resistance. Balancing the availability of antibiotics while promoting responsible usage is an ongoing challenge. Addressing this requires robust public health campaigns, healthcare provider education, and collaborations between the medical community and regulatory bodies.
The Indonesia antibiotic market plays a vital role in healthcare. The pandemic highlighted the importance of robust healthcare infrastructure. While antibiotics remain essential, their overuse and antimicrobial resistance are ongoing challenges. Balancing antibiotic use for patient care while mitigating resistance requires a collaborative effort involving healthcare professionals, regulatory bodies, and pharmaceutical companies.
The Indonesia antibiotic market is of critical importance in the healthcare sector, driven by the prevalence of infectious diseases and the need for effective treatments. Factors such as growing populations, increased urbanization, and changes in healthcare infrastructure contribute to the demand for antibiotics. Key drivers include the emergence of antibiotic-resistant pathogens, ongoing research and development efforts to create new antibiotics, and government initiatives to improve healthcare access. Leading pharmaceutical companies like MediPharm Indo, CureWell Pharmaceuticals, and Healix Laboratories are positioned to address these challenges by producing essential antibiotics and innovative treatment options.
1 Executive Summary  | 
2 Introduction  | 
2.1 Key Highlights of the Report  | 
2.2 Report Description  | 
2.3 Market Scope & Segmentation  | 
2.4 Research Methodology  | 
2.5 Assumptions  | 
3 Indonesia Antibiotic Market Overview  | 
3.1 Indonesia Country Macro Economic Indicators  | 
3.2 Indonesia Antibiotic Market Revenues & Volume, 2021 & 2031F  | 
3.3 Indonesia Antibiotic Market - Industry Life Cycle  | 
3.4 Indonesia Antibiotic Market - Porter's Five Forces  | 
3.5 Indonesia Antibiotic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F  | 
3.6 Indonesia Antibiotic Market Revenues & Volume Share, By Application, 2021 & 2031F  | 
3.7 Indonesia Antibiotic Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F  | 
3.8 Indonesia Antibiotic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F  | 
4 Indonesia Antibiotic Market Dynamics  | 
4.1 Impact Analysis  | 
4.2 Market Drivers  | 
4.2.1 Increasing prevalence of infectious diseases in Indonesia  | 
4.2.2 Growing awareness about the importance of antibiotics in healthcare  | 
4.2.3 Rising healthcare expenditure in the country  | 
4.3 Market Restraints  | 
4.3.1 Antibiotic resistance leading to decreased effectiveness of existing antibiotics  | 
4.3.2 Regulatory challenges and government policies impacting antibiotic usage  | 
4.3.3 High competition among antibiotic manufacturers leading to pricing pressures  | 
5 Indonesia Antibiotic Market Trends  | 
6 Indonesia Antibiotic Market, By Types  | 
6.1 Indonesia Antibiotic Market, By Drug Class  | 
6.1.1 Overview and Analysis  | 
6.1.2 Indonesia Antibiotic Market Revenues & Volume, By Drug Class, 2021-2031F  | 
6.1.3 Indonesia Antibiotic Market Revenues & Volume, By Penicillin, 2021-2031F  | 
6.1.4 Indonesia Antibiotic Market Revenues & Volume, By Cephalosporin, 2021-2031F  | 
6.1.5 Indonesia Antibiotic Market Revenues & Volume, By Aminoglycosides, 2021-2031F  | 
6.1.6 Indonesia Antibiotic Market Revenues & Volume, By Tetracycline, 2021-2031F  | 
6.1.7 Indonesia Antibiotic Market Revenues & Volume, By Macrolides, 2021-2031F  | 
6.1.8 Indonesia Antibiotic Market Revenues & Volume, By Fluoroquinolones, 2021-2031F  | 
6.1.9 Indonesia Antibiotic Market Revenues & Volume, By Others, 2021-2031F  | 
6.1.10 Indonesia Antibiotic Market Revenues & Volume, By Others, 2021-2031F  | 
6.2 Indonesia Antibiotic Market, By Application  | 
6.2.1 Overview and Analysis  | 
6.2.2 Indonesia Antibiotic Market Revenues & Volume, By Skin Infections, 2021-2031F  | 
6.2.3 Indonesia Antibiotic Market Revenues & Volume, By Respiratory Infections, 2021-2031F  | 
6.2.4 Indonesia Antibiotic Market Revenues & Volume, By Urinary Tract Infections, 2021-2031F  | 
6.2.5 Indonesia Antibiotic Market Revenues & Volume, By Septicemia, 2021-2031F  | 
6.2.6 Indonesia Antibiotic Market Revenues & Volume, By Ear Infection, 2021-2031F  | 
6.2.7 Indonesia Antibiotic Market Revenues & Volume, By Gastrointestinal Infections, 2021-2031F  | 
6.3 Indonesia Antibiotic Market, By Route of Administration  | 
6.3.1 Overview and Analysis  | 
6.3.2 Indonesia Antibiotic Market Revenues & Volume, By Oral, 2021-2031F  | 
6.3.3 Indonesia Antibiotic Market Revenues & Volume, By Parenteral, 2021-2031F  | 
6.3.4 Indonesia Antibiotic Market Revenues & Volume, By Others, 2021-2031F  | 
6.4 Indonesia Antibiotic Market, By Distribution Channel  | 
6.4.1 Overview and Analysis  | 
6.4.2 Indonesia Antibiotic Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F  | 
6.4.3 Indonesia Antibiotic Market Revenues & Volume, By Retail Pharmacy, 2021-2031F  | 
6.4.4 Indonesia Antibiotic Market Revenues & Volume, By Online Pharmacy, 2021-2031F  | 
7 Indonesia Antibiotic Market Import-Export Trade Statistics  | 
7.1 Indonesia Antibiotic Market Export to Major Countries  | 
7.2 Indonesia Antibiotic Market Imports from Major Countries  | 
8 Indonesia Antibiotic Market Key Performance Indicators  | 
8.1 Percentage increase in antibiotic prescriptions in Indonesia  | 
8.2 Rate of adoption of newer, more effective antibiotics in the market  | 
8.3 Investment in research and development for antibiotic innovation  | 
9 Indonesia Antibiotic Market - Opportunity Assessment  | 
9.1 Indonesia Antibiotic Market Opportunity Assessment, By Drug Class, 2021 & 2031F  | 
9.2 Indonesia Antibiotic Market Opportunity Assessment, By Application, 2021 & 2031F  | 
9.3 Indonesia Antibiotic Market Opportunity Assessment, By Route of Administration, 2021 & 2031F  | 
9.4 Indonesia Antibiotic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F  | 
10 Indonesia Antibiotic Market - Competitive Landscape  | 
10.1 Indonesia Antibiotic Market Revenue Share, By Companies, 2024  | 
10.2 Indonesia Antibiotic Market Competitive Benchmarking, By Operating and Technical Parameters  | 
11 Company Profiles  | 
12 Recommendations  | 
13 Disclaimer  |